Literature DB >> 12029624

Diminished hepatic expression of the HNF-6 transcription factor during bile duct obstruction.

Ai-Xuan L Holterman1, Yongjun Tan, Wooram Kim, Kyung W Yoo, Robert H Costa.   

Abstract

Hepatocyte nuclear factor 6 (HNF-6) is a member of the one cut family of transcription factors and potentially regulates expression of numerous target genes important for hepatocyte function. In the liver, HNF-6 is expressed not only in hepatocytes, but also in biliary epithelial cells (BEC). To evaluate the in vivo function of HNF-6, we examined the hepatic expression pattern of HNF-6 messenger RNA (mRNA) and protein after bile duct ligation (BDL)-mediated liver injury. We found that HNF-6 protein levels in BEC and hepatocytes were diminished within 15 hours of BDL injury and remained suppressed through the fifth day of injury. The onset of BEC proliferation in response to bile duct obstruction was associated with diminished HNF-6 protein levels. To maintain hepatic HNF-6 protein levels during BDL liver injury, we used mouse tail vein injections with recombinant adenovirus expressing HNF-6 complementary DNA (cDNA) (AdH6). We found that maintaining hepatic HNF-6 levels with AdH6 infection resulted in significant decreases in BEC proliferation at 15 and 24 hours after biliary obstruction compared with adenovirus control. Our results showed that HNF-6 expression is diminished in BEC and hepatocytes and that maintaining hepatic HNF-6 expression hinders the normal biliary proliferative response to bile duct injury. This suggests that diminished hepatic HNF-6 levels are required for repair in response to biliary injury and that it regulates expression of genes that possess differentiation-specific function that are inhibitory to proliferation. In conclusion, we propose a biologic role for diminished HNF-6 protein levels in bile duct disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029624     DOI: 10.1053/jhep.2002.33680

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

1.  Hepatocyte nuclear factor 6 suppresses the migration and invasive growth of lung cancer cells through p53 and the inhibition of epithelial-mesenchymal transition.

Authors:  Xin-Wang Yuan; Dong-Mei Wang; Ying Hu; Yun-Neng Tang; Wei-Wei Shi; Xiao-Jie Guo; Jian-Guo Song
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

2.  Intrahepatic bile duct regeneration in mice does not require Hnf6 or Notch signaling through Rbpj.

Authors:  Teagan J Walter; Charles Vanderpool; Ashley E Cast; Stacey S Huppert
Journal:  Am J Pathol       Date:  2014-03-13       Impact factor: 4.307

3.  Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts.

Authors:  S Glaser; M Wang; Y Ueno; J Venter; K Wang; H Chen; G Alpini; A Holterman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-06-24       Impact factor: 4.052

4.  Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6.

Authors:  Ruidong Hao; Jing He; Xing Liu; Guozhen Gao; Dan Liu; Lei Cui; Guojun Yu; Wenhui Yu; Yu Chen; Deyin Guo
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

5.  Genetic interactions between hepatocyte nuclear factor-6 and Notch signaling regulate mouse intrahepatic bile duct development in vivo.

Authors:  Charles Vanderpool; Erin E Sparks; Kari A Huppert; Maureen Gannon; Anna L Means; Stacey S Huppert
Journal:  Hepatology       Date:  2012-01       Impact factor: 17.425

6.  Activation of pancreatic-duct-derived progenitor cells during pancreas regeneration in adult rats.

Authors:  Wan-Chun Li; J Michael Rukstalis; Wataru Nishimura; Vaja Tchipashvili; Joel F Habener; Arun Sharma; Susan Bonner-Weir
Journal:  J Cell Sci       Date:  2010-07-27       Impact factor: 5.285

7.  Increased expression of hepatocyte nuclear factor 6 stimulates hepatocyte proliferation during mouse liver regeneration.

Authors:  Yongjun Tan; Yuichi Yoshida; Douglas E Hughes; Robert H Costa
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

8.  Study protocol of Phase 2 open-label multicenter randomized controlled trial for granulocyte-colony stimulating factor (GCSF) in post-Kasai Type 3 biliary atresia.

Authors:  Hoa Pham Anh Nguyen; Jinma Ren; Marilyn Butler; Henri Li; Saqib Qazi; Kamran Sadiq; Hieu Trung Dao; AiXuan Holterman
Journal:  Pediatr Surg Int       Date:  2022-04-07       Impact factor: 1.827

9.  Is extended hepatectomy for hepatobiliary malignancy justified?

Authors:  Jean-Nicolas Vauthey; Timothy M Pawlik; Eddie K Abdalla; James F Arens; Rabih A Nemr; Steven H Wei; Debra L Kennamer; Lee M Ellis; Steven A Curley
Journal:  Ann Surg       Date:  2004-05       Impact factor: 12.969

10.  Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice.

Authors:  Minhua Wang; Michael Chen; Guoqiang Zheng; Barney Dillard; Mike Tallarico; Zorayda Ortiz; Ai-Xuan Holterman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.